Marc Ullman was quoted in a Natural Products Insider article, “Hi-Tech sues FDA over DMHA enforcement.” The article discusses how Hi-Tech complained that FDA’s “arbitrary and capricious” enforcement against the stimulant threatens its CEO Jared Wheat’s bond stipulations in a multi-count federal criminal indictment.

“A botanical might have been marketed as a dietary ingredient [before DSHEA],

Chris Kutner was quoted in a Managed Care article, “Centene, big in Medicaid managed care, wants to get even bigger.” The article discusses how Centene, the country’s largest Medicaid managed care company, is hoping its proposed acquisition of WellCare will be small enough to fly under the radar while helping to bolster its lead in the

Kate Heptig, with help from Stacey Goldstein and Margarita Christoforou, created a new medical group, PRINE Health, that will focus on value-based care for patients with chronic kidney disease.  The resulting medical practice, PRINE Health Medical Group, PLLC, is comprised of thirty providers from six existing independent medical practices, including nephrologists and primary care physicians,

Uniondale, New York – April 25, 2019 – The prestigious Chambers USA Directory has once again included Rivkin Radler LLP in its New York rankings.  The firm’s Insurance Coverage Practice Group is ranked in Band 3 in the Insurance: Dispute Resolution: Insurer category and its Health Services Practice Group ranked in Band 4 in the

Marc Ullman was quoted in a Natural Products Insider article, “The Vitamin Shoppe to carry CBD following FDA’s move to exercise ‘enforcement discretion.'” The article discusses the FDA’s announcement to exercise “enforcement discretion” related to foods and supplements containing CBD as a factor driving mass-market retailer activity in the category, including The Vitamin Shoppe’s recent move

Marc Ullman was quoted in a NutraIngredients-USA article, “FDA sends warnings letters on illegal ingredients in sports, weight loss products.” The article discusses the 11 warning letters that were sent to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA and the other three concerned phenibut.

Ullman has

Marc Ullman was quoted in a NutraIngredients-USA article, “FDA’s new advisory list receives mixed reactions from industry.” The article discusses how the FDA announced a new ‘rapid communication tool,’ called the Dietary Ingredient Advisory List. Trade groups and industry experts applauded the effort, but many opined that this step still has much left to be

Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements.

“Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter?

Robert Iseman penned a Thought Leaders Corner column for Population Health News in which he makes suggestions regarding how healthcare organizations can manage the social determinants of health (SDOH) within their patient population.

Robert noted, among other things, “It is easy for a health system to get carried away in the world of SDOH. It is

Cassandra Rivais was selected to serve as a reviewer for the abstracts of American Society of Bioethics and Humanities’ annual conference.  The organization hand-picks who will serve as reviewers, and reviewers get special recognition during the conference program.